Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.22.2.2
Subsequent Events (Details)
3 Months Ended
Nov. 10, 2022
USD ($)
installment
Oct. 17, 2022
USD ($)
Sep. 30, 2022
USD ($)
Emerald Health Therapeutics, Inc.      
Subsequent Event [Line Items]      
Working capital loan     $ 700,000
Subsequent Event      
Subsequent Event [Line Items]      
Interest rate (as a percent) 5.00% 12.00%  
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary      
Subsequent Event [Line Items]      
Aggregate purchase price $ 9,312,000    
Non-refundable deposit 548,000    
Amount paid $ 6,026,000    
Number of installments | installment 3    
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary | Total Installment      
Subsequent Event [Line Items]      
Amount paid $ 913,000    
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary | Installment Term One      
Subsequent Event [Line Items]      
Installment term 18 months    
Basis spread 1.55%    
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary | Installment Term Two      
Subsequent Event [Line Items]      
Installment term 30 months    
Basis spread 3.55%    
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary | Installment Term Three      
Subsequent Event [Line Items]      
Installment term 42 months    
Basis spread 5.55%    
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary | Installment Term Upon Prepayment      
Subsequent Event [Line Items]      
Basis spread 1.55%    
Subsequent Event | Emerald Health Therapeutics, Inc.      
Subsequent Event [Line Items]      
Working capital loan   $ 700,000